Title:
METHODS OF ADMINISTERING PIRFENIDONE THERAPY
Document Type and Number:
Japanese Patent JP2017145262
Kind Code:
A
Abstract:
PROBLEM TO BE SOLVED: To provide methods involving avoiding adverse drug interactions with fluvoxamine and pirfenidone or other moderate to strong inhibitors of CYP enzymes.SOLUTION: The invention generally relates to improved uses and methods of administering pirfenidone to a patient in need of pirfenidone therapy, and to methods of preparing or packaging pirfenidone medicaments, containers, packages and kits.SELECTED DRAWING: None
Inventors:
WILLIAMSON ZIEGLER BRADFORD
JAVIER SZWARCBERG
JAVIER SZWARCBERG
Application Number:
JP2017110731A
Publication Date:
August 24, 2017
Filing Date:
June 05, 2017
Export Citation:
Assignee:
INTERMUNE INC
International Classes:
C07D213/64; A61K31/4418; A61P1/04; A61P1/12; A61P1/16; A61P1/18; A61P3/00; A61P3/10; A61P7/00; A61P7/02; A61P7/06; A61P9/00; A61P9/04; A61P9/06; A61P9/10; A61P11/00; A61P11/02; A61P11/06; A61P13/08; A61P13/12; A61P17/00; A61P19/00; A61P19/02; A61P19/06; A61P19/10; A61P21/00; A61P21/04; A61P25/00; A61P25/04; A61P25/06; A61P25/14; A61P25/16; A61P25/28; A61P27/02; A61P27/14; A61P29/00; A61P29/02; A61P31/04; A61P31/14; A61P31/16; A61P31/18; A61P31/20; A61P31/22; A61P33/02; A61P33/06; A61P35/00; A61P35/02; A61P35/04; A61P37/00; A61P37/06; A61P37/08; A61P41/00; A61P43/00
Other References:
ピレスパ（登録商標）錠２００ＭＧ 添付文書, JPN6014050651, June 2009 (2009-06-01)
嶋村京子, ちば県薬誌, vol. Vol. 55, No. 6, JPN6012009503, May 2009 (2009-05-01), pages pp. 23-27
ピレスパ錠審議結果報告書, JPN6012065881, September 2008 (2008-09-01)
AZUMA, A. ET AL., AM. J. RESPIR. CRIT. CARE MED., vol. Vol. 171, JPN7012000677, 2005, pages pp. 1040-1047
臨床薬理, vol. Vol. 31, No. 2, JPN6012065884, 2000, pages pp. 411-412
"抗精神病薬の副作用と相互作用", 別冊 日本臨牀 領域別症候群シリーズ ＮＯ．３８ 精神医学症候群（Ｉ）—統合失調症と周縁疾患など—, JPN6012065886, 2003, pages pp. 172-175
澤田 康文 ほか: "抗うつ薬の薬物動態と相互作用", 日本臨牀, vol. Vol. 59, No. 8, JPN6012065889, 2001, pages pp. 1539-1545
中野 眞汎: "併用薬による代謝促進・阻害とその対策", 医学のあゆみ, vol. Vol. 170, No. 11, JPN6012065890, 1994, pages pp. 959-962
CURRENT DRUG METABOLISM, vol. 3(1), JPN6012065895, 2002, pages 13-37
嶋村京子, ちば県薬誌, vol. Vol. 55, No. 6, JPN6012009503, May 2009 (2009-05-01), pages pp. 23-27
ピレスパ錠審議結果報告書, JPN6012065881, September 2008 (2008-09-01)
AZUMA, A. ET AL., AM. J. RESPIR. CRIT. CARE MED., vol. Vol. 171, JPN7012000677, 2005, pages pp. 1040-1047
臨床薬理, vol. Vol. 31, No. 2, JPN6012065884, 2000, pages pp. 411-412
"抗精神病薬の副作用と相互作用", 別冊 日本臨牀 領域別症候群シリーズ ＮＯ．３８ 精神医学症候群（Ｉ）—統合失調症と周縁疾患など—, JPN6012065886, 2003, pages pp. 172-175
澤田 康文 ほか: "抗うつ薬の薬物動態と相互作用", 日本臨牀, vol. Vol. 59, No. 8, JPN6012065889, 2001, pages pp. 1539-1545
中野 眞汎: "併用薬による代謝促進・阻害とその対策", 医学のあゆみ, vol. Vol. 170, No. 11, JPN6012065890, 1994, pages pp. 959-962
CURRENT DRUG METABOLISM, vol. 3(1), JPN6012065895, 2002, pages 13-37
Attorney, Agent or Firm:
Shinichiro Tanaka
Disciple Maru Ken
Atsushi Hakoda
Kenji Asai
Kazuo Yamazaki
Satsuki Ichikawa
Hironobu Hattori
Disciple Maru Ken
Atsushi Hakoda
Kenji Asai
Kazuo Yamazaki
Satsuki Ichikawa
Hironobu Hattori